# Effect of Dapagliflozin on IAH in T1DM

> **NCT03556033** · PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 15 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1
- Hypoglycemia
- Hypoglycemia Unawareness

## Interventions

- **DRUG:** Dapagliflozin
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03556033
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-23
- **Primary completion:** 2019-12-20
- **Final completion:** 2019-12-20
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03556033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03556033, "Effect of Dapagliflozin on IAH in T1DM". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03556033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*